Connect with us

JFL Life Sciences IPO

Incorporated in 2010, JFL Life Sciences Limited is engaged in the business of manufacturing of pharmaceutical products. The company’s product portfolio consists of Dry powder injections (B-Lactam), Tablets & Capsules (B-Lactam) solid oral dosage form and Tablet and capsules (general) Solid Oral Dosage Form and Oral rehydration solutions (ORS).

The company’s sales strategy is to sell the products in bulk to pharmaceutical marketers and traders who in turn provide the channel for sales to customers. JFL Life Sciences Limited has a market presence in PAN India and JFL’s products are supplied to 10 developed and developing countries throughout the World.

JFL Life Sciences Limited exports products to African, Middle Eastern, and CIS countries, mainly through merchant exporters. The company is registered with the MOH of Kenya, Nigeria, Yemen, Cambodia & Myanmar for manufacturing a particular product. Few of our products are also registered with Ukraine, Uzbekistan, and Kazakhstan (CIS countries) through merchants.

JFL has two manufacturing units (on lease) in Gujarat.

Competitive Strength :

  1. Product registration
  2. Experienced management and dedicated employee base
  3. Quality assurance
  4. Quality & Brand strength

Company Financials

Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthReserves and Surplus
31-Aug-191614.963177.9630.25501.49459.2
31-Mar-202432.593020.4136.04537.53495.24
31-Mar-212900.693286.8954.21687.25637.55
28-Feb-223662.862563.06253.281096.52294.48
Amount in ₹ Lakhs

Objects of the Issue

The Company proposes to utilize the funds which are being raised through this Issue (“Net Proceeds”) towards the following objects:

  1. Repayment of secured and unsecured loans.
  2. Funding the working capital requirements of the company.
  3. General Corporate Purposes

IPO Details

JFL Life Sciences IPO DateAug 25, 2022 to Aug 30, 2022
JFL Life Sciences IPO Face Value₹10 per share
JFL Life Sciences IPO Price₹61 per share
JFL Life Sciences IPO Lot Size2000 Shares
Issue Size2,978,000 shares of ₹10
(aggregating up to ₹18.17 Cr)
Fresh Issue2,978,000 shares of ₹10
(aggregating up to ₹18.17 Cr)
Issue TypeFixed Price Issue IPO
Listing AtNSE SME
Retail Shares Offered50% of the net offer
NII (HNI) Shares Offered50% of the net offer
Company PromotersSmiral Ashwinkumar Patel and Tejal Smiral Patel are the company promoters.

IPO Timeline

IPO opens on Aug 25, 2022, and closes on Aug 30, 2022. IPO bid date is from Aug 25, 2022 10.00 A.M. to Aug 30, 2022 5.00 P.M. The Cut-off time for UPI Mandate confirmation is 12 P.M. on the next day of issue closing day.

EventDate
JFL Life Sciences IPO Opening DateAug 25, 2022
JFL Life Sciences IPO Closing DateAug 30, 2022
Basis of AllotmentSep 5, 2022
Initiation of RefundsSep 6, 2022
Credit of Shares to DematSep 7, 2022
JFL Life Sciences IPO Listing DateSep 8, 2022

IPO Lot Size

The IPO lot size is 2000 shares. A retail-individual investor can apply for up to 1 lots (2000 shares or ₹122,000).

ApplicationLotsSharesAmount
Minimum12000₹122,000
Maximum12000₹122,000

IPO Promoter Holding

Pre Issue Share Holding92.52%
Post Issue Share Holding67.47%

IPO Prospectus

Company Contact Information

JFL Life Sciences Limited
309, Satyam Mall,
Opp. Saman Complex, Nr. Vishweshwar Mahadev Mandir
Settelite, Ahmedabad 380015
Phone: 937729 5575
Email: [email protected]
Websitehttp://www.jfllifesciences.com/

IPO Registrar

KFin Technologies Limited

Phone: 04067162222, 04079611000
Email: [email protected]
Websitehttps://karisma.kfintech.com/

IPO Lead Manager(s)

  1. GYR Capital Advisors Limited